Brigit Biofarmaka Teknologi Tbk. vs Sarana Mitra Luas Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume), while Sarana Mitra Luas Tbk. trades at Rp380 (market cap 3.31T, 9.71M 24h volume). The key difference: Sarana Mitra Luas Tbk. is far larger — about 20.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Sarana Mitra Luas Tbk. is more actively traded (9.71M versus 43.9K). Which is the better fit depends on your goals.
| OBAT | SMIL | |
|---|---|---|
Market Cap | 164.65B | 3.31T |
Volume | 43.9K | 9.71M |
Lot | 439 | 97.07K |
Turnover | 10.6M | 3.66B |
Average Price | 241.43 | 376.76 |
Value | 10.6M | 3.66B |
Indicative Equilibrium Price | 238 | 376 |
Indicative Equilibrium Volume | 100 | 179 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Sarana Mitra Luas Tbk (the Company) was established on Sep 28, 2006 based on Notarial Deed No. 06 of Fransiska Bonita Maya Dwi Tanti, S.H., notary in Bekasi. The Company started its commercial operations in 2006.
Read more on SMIL →